ensembl_id string | gene string | gene_description string | uniprot list | chromosome string | position string | evidence string | hpa_evidence string | uniprot_evidence string | nextprot_evidence string | antibodies list | gene_synonyms list | protein_classes list | biological_processes list | molecular_functions list | disease_involvement list | subcellular_main_locations list | subcellular_additional_locations list | secretome_locations list | secretome_functions list | reliability_if string | reliability_ih string | reliability_mouse_brain string | interactions float64 | ccd_protein string | ccd_transcript string | blood_expression_cluster string | brain_expression_cluster string | cell_line_expression_cluster string | single_cell_expression_cluster string | tissue_expression_cluster string | rna_tissue_specificity string | rna_tissue_distribution string | rna_tissue_specificity_score float64 | rna_cell_line_specificity string | rna_cell_line_distribution string | rna_cell_line_specificity_score float64 | rna_cancer_specificity string | rna_cancer_distribution string | rna_cancer_specificity_score float64 | rna_single_cell_type_specificity string | rna_single_cell_type_distribution string | rna_single_cell_type_specificity_score float64 | rna_blood_cell_specificity string | rna_blood_cell_distribution string | rna_blood_cell_specificity_score float64 | prognostic_cancer_count int64 | validated_prognostic_cancer_count int64 | potential_prognostic_cancer_count int64 | favorable_prognostic_cancers list | unfavorable_prognostic_cancers list | prognostic_cancers list | source_row_index int64 | split_bucket int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ENSG00000168010 | ATG16L2 | Autophagy related 16 like 2 | [
"Q8NAA4"
] | 11 | 72814406-72843674 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA045444",
"HPA050312"
] | [
"ATG16B",
"FLJ00012",
"WDR80"
] | [
"Predicted intracellular proteins",
"Transporters"
] | [
"Protein transport",
"Transport"
] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Approved | null | 5 | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 48: Non-specific - Mixed function | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 24: Neutrophils - Innate immunity signal integration | Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 4 | Immune cell enhanced | Detected in all | null | 2 | 0 | 2 | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 12,032 | 2 |
ENSG00000168014 | C2CD3 | C2 domain containing 3 centriole elongation regulator | [
"Q4AC94"
] | 11 | 74012718-74171210 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038552",
"HPA038553",
"HPA040433"
] | [
"DKFZP586P0123"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Cilium biogenesis/degradation"
] | [] | [
"Ciliopathy",
"Disease variant",
"Intellectual disability"
] | [
"Nucleoplasm",
"Centrosome",
"Basal body"
] | [
"Acrosome",
"Equatorial segment",
"Principal piece"
] | [] | [] | Supported | Approved | null | 3 | null | null | Cluster 32: Basophils - Transcription | Cluster 48: Non-specific - Mixed function | Cluster 72: Neuronal - Signal transduction | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 48: Ciliated tissues - Cilium organization | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Low cell type specificity | Detected in all | null | Immune cell enhanced | Detected in all | null | 2 | 0 | 2 | [] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 12,033 | 1 |
ENSG00000168016 | TRANK1 | Tetratricopeptide repeat and ankyrin repeat containing 1 | [
"O15050"
] | 3 | 36826819-36945057 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA035508"
] | [
"KIAA0342",
"LBA1"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Approved | null | null | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 46: Lymphoma - Humoral immune response | Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier | Cluster 61: Non-specific - Transcription | Low tissue specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in many | 7 | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,034 | 9 |
ENSG00000168026 | TTC21A | Tetratricopeptide repeat domain 21A | [
"Q8NDW8"
] | 3 | 39107680-39138903 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA035510",
"HPA035511"
] | [
"IFT139A",
"STI2",
"Thm2"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Differentiation",
"Spermatogenesis"
] | [] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Enhanced | null | 4 | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 17: Choroid plexus - Cilium | Cluster 46: Lymphoma - Humoral immune response | Cluster 34: Ciliated cells - Cilia assembly & function | Cluster 57: Testis - Spermatogenesis | Tissue enriched | Detected in some | 6 | Low cancer specificity | Detected in some | null | Not detected | Not detected | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,035 | 6 |
ENSG00000168028 | RPSA | Ribosomal protein SA | [
"P08865"
] | 3 | 39406716-39426255 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB009561"
] | [
"37LRP",
"LAMR1",
"LRP",
"p40",
"SA"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Ribosomal proteins"
] | [
"Host-virus interaction"
] | [
"Host cell receptor for virus entry",
"Receptor",
"Ribonucleoprotein",
"Ribosomal protein"
] | [
"Disease variant"
] | [
"Plasma membrane",
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 257 | null | null | Cluster 24: Non-specific - Transcription | Cluster 7: Non-specific - Ribosome | Cluster 25: Non-specific - Ribosome | Cluster 15: Non-specific - Protein processing | Cluster 54: Non-specific - Ribosome | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Glioblastoma Multiforme"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma"
] | 12,036 | 2 |
ENSG00000168032 | ENTPD3 | Ectonucleoside triphosphate diphosphohydrolase 3 | [
"O75355"
] | 3 | 40387184-40428744 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA071802"
] | [
"CD39L3",
"HB6",
"NTPDase-3"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted membrane proteins"
] | [] | [
"Hydrolase"
] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | null | null | 1 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 32: Cerebral cortex - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 69: Urothelial cells - Basic cellular functions | Cluster 36: Brain & Liver - Signaling | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Immune cell enriched | Detected in single | 7 | 1 | 0 | 1 | [
"Pancreatic Adenocarcinoma"
] | [] | [
"Pancreatic Adenocarcinoma"
] | 12,037 | 8 |
ENSG00000168036 | CTNNB1 | Catenin beta 1 | [
"P35222"
] | 3 | 41194741-41260096 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB000108",
"CAB001950",
"HPA029159",
"HPA029160"
] | [
"armadillo",
"beta-catenin",
"CTNNB"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Cell adhesion",
"Host-virus interaction",
"Neurogenesis",
"Transcription",
"Transcription regulation",
"Wnt signaling pathway"
] | [
"Activator"
] | [
"Cancer-related genes",
"Disease variant",
"Intellectual disability"
] | [
"Plasma membrane"
] | [
"Cell Junctions",
"Primary cilium",
"Basal body"
] | [] | [] | Enhanced | Supported | null | 443 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 44: Non-specific - Mixed function | Cluster 9: Skin cancer - Melanin biosynthesis | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,038 | 7 |
ENSG00000168038 | ULK4 | Unc-51 like kinase 4 | [
"Q96C45"
] | 3 | 41246599-41962130 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA017930"
] | [
"FAM7C1",
"FLJ20574",
"REC01035"
] | [
"Disease related genes",
"Enzymes",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [] | [
"Primary cilium transition zone",
"Cytosol"
] | [] | [] | [] | Approved | Uncertain | null | 2 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 17: Choroid plexus - Cilium | Cluster 8: Non-specific - Basic cellular processes | Cluster 34: Ciliated cells - Cilia assembly & function | Cluster 56: Ciliated tissues - Cilium organization | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe"
] | 12,039 | 1 |
ENSG00000168040 | FADD | Fas associated via death domain | [
"Q13158"
] | 11 | 70203296-70207390 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA001464",
"CAB010209"
] | [
"GIG3",
"MORT1"
] | [
"Cancer-related genes",
"Disease related genes",
"Predicted intracellular proteins"
] | [
"Apoptosis",
"Host-virus interaction",
"Immunity",
"Innate immunity"
] | [] | [
"Cancer-related genes",
"Disease variant"
] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Supported | Supported | null | 60 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 44: Non-specific - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 63: Cytotrophoblasts - Basic cellular functions | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 2 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 12,040 | 5 |
ENSG00000168060 | NAALADL1 | N-acetylated alpha-linked acidic dipeptidase like 1 | [
"Q9UQQ1"
] | 11 | 65044818-65058553 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA047123"
] | [
"HILAP"
] | [
"Enzymes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Aminopeptidase",
"Hydrolase",
"Metalloprotease",
"Protease"
] | [] | [
"Cytosol"
] | [] | [] | [] | Uncertain | Enhanced | null | null | null | null | Cluster 46: Basophils - Proteolysis | Cluster 42: Choroid plexus - Mitochondria | Cluster 64: Connective tissue cells - ECM organization | Cluster 1: Enterocytes - Absorption and Digestion | Cluster 77: Intestine - Digestion | Tissue enriched | Detected in all | 4 | Low cancer specificity | Detected in some | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 24 | Immune cell enhanced | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 12,042 | 7 |
ENSG00000168061 | SAC3D1 | SAC3 domain containing 1 | [] | 11 | 65040901-65044828 | Evidence at transcript level | Evidence at transcript level | null | null | [
"HPA042677"
] | [
"HSU79266",
"SHD1"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | Uncertain | null | 1 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 18: Non-specific - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 67: Testis - Mixed function | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 2 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,043 | 1 |
ENSG00000168062 | BATF2 | Basic leucine zipper ATF-like transcription factor 2 | [
"Q8N1L9"
] | 11 | 64987945-64997018 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA062496"
] | [
"MGC20410"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Differentiation",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [] | [
"Nucleoli"
] | [] | [] | [] | Approved | Approved | null | 12 | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 43: Hindbrain - Mixed function | Cluster 51: Myeloma - Immunoglobulins | Cluster 65: Non-specific - Cell growth & division | Cluster 60: Stomach - Digestion | Low tissue specificity | Detected in many | null | Cancer enriched | Detected in many | 5 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 4 | 1 | 0 | 1 | [] | [
"Pancreatic Adenocarcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | 12,044 | 9 |
ENSG00000168065 | SLC22A11 | Solute carrier family 22 member 11 | [
"Q9NSA0"
] | 11 | 64555690-64572875 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA026076"
] | [
"OAT4"
] | [
"FDA approved drug targets",
"Metabolic proteins",
"Plasma proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Anion exchange",
"Antiport",
"Ion transport",
"Transport"
] | [] | [
"FDA approved drug targets"
] | [] | [] | [] | [] | null | Enhanced | null | 1 | null | null | null | null | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 39: Syncytiotrophoblasts - Placental homeostasis & endocrine signal | Cluster 72: Kidney - Transmembrane transport | Group enriched | Detected in some | 69 | Not detected | Not detected | null | Group enriched | Detected in some | 5 | Group enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 12,045 | 2 |
ENSG00000168066 | SF1 | Splicing factor 1 | [
"Q15637"
] | 11 | 64764606-64778786 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA018883"
] | [
"ZCCHC25",
"ZFM1",
"ZNF162"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing",
"Transcription",
"Transcription regulation"
] | [
"Repressor",
"RNA-binding"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Supported | null | 63 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 16: Non-specific - Transcription | Cluster 24: Non-specific - Unknown function | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 12,046 | 5 |
ENSG00000168067 | MAP4K2 | Mitogen-activated protein kinase kinase kinase kinase 2 | [
"Q12851"
] | 11 | 64784918-64803241 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA007330"
] | [
"BL44",
"GCK",
"RAB8IP"
] | [
"Enzymes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Immunity",
"Innate immunity",
"Stress response"
] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [] | [
"Vesicles"
] | [] | [] | [] | Approved | Enhanced | null | 10 | null | null | Cluster 14: Non-specific - Unknown function | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 46: Lymphoma - Humoral immune response | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 5: Spleen - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,047 | 4 |
ENSG00000168070 | MAJIN | Membrane anchored junction protein | [
"Q3KP22"
] | 11 | 64937517-64972108 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"C11orf85"
] | [
"Predicted intracellular proteins"
] | [
"Meiosis"
] | [
"DNA-binding"
] | [] | [] | [] | [] | [] | null | null | null | 1 | null | null | Cluster 14: Non-specific - Unknown function | Cluster 15: Non-specific - Transcription | Cluster 46: Lymphoma - Humoral immune response | Cluster 3: Early primary spermatocytes - Early meiosis | Cluster 57: Testis - Spermatogenesis | Tissue enriched | Detected in some | 8 | Cancer enriched | Detected in some | 12 | Cancer enhanced | Detected in some | null | Cell type enriched | Detected in many | 7 | Immune cell enhanced | Detected in single | null | 1 | 0 | 1 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | [] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma"
] | 12,048 | 1 |
ENSG00000168071 | CCDC88B | Coiled-coil domain containing 88B | [
"A6NC98"
] | 11 | 64340204-64357534 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA026652"
] | [
"BRLZ",
"CCDC88",
"FLJ00354",
"FLJ37970",
"GIPIE",
"HkRP3"
] | [
"Predicted intracellular proteins"
] | [
"Stress response"
] | [] | [] | [
"Centrosome",
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Supported | Approved | null | 32 | null | null | Cluster 22: Eosinophils - Transcription | Cluster 50: Non-specific - Nucleic acid binding | Cluster 35: RS4;11 - Unknown function | Cluster 48: Neutrophils - Phagocytosis & degranulation | Cluster 64: Non-specific - Transcription | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 5 | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Head and Neck Squamous Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 12,049 | 6 |
ENSG00000168077 | SCARA3 | Scavenger receptor class A member 3 | [
"Q6AZY7"
] | 8 | 27633868-27676776 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA029861",
"HPA047386"
] | [
"APC7",
"CSR",
"CSR1",
"MSLR1",
"MSRL1"
] | [
"Predicted membrane proteins"
] | [] | [] | [] | [
"Endoplasmic reticulum"
] | [] | [] | [] | Supported | Uncertain | null | 5 | null | null | null | Cluster 44: Non-specific - Mixed function | Cluster 72: Neuronal - Signal transduction | Cluster 38: Secretory epithelial cells - Exocrine secretion | Cluster 74: Non-specific - Signal transduction | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,050 | 2 |
ENSG00000168078 | PBK | PDZ binding kinase | [
"Q96KB5"
] | 8 | 27809624-27838082 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA005753",
"HPA050656"
] | [
"CT84",
"FLJ14385",
"Nori-3",
"SPK",
"TOPK"
] | [
"Enzymes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [
"Kinase",
"Serine/threonine-protein kinase",
"Transferase"
] | [] | [
"Cytosol"
] | [] | [] | [] | Approved | Enhanced | Supported | 44 | null | Yes | Cluster 9: T-regs - Cell cycle regulation | null | Cluster 40: Non-specific - Unknown function | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 39: Testis - Nuclear processes | Group enriched | Detected in many | 5 | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Group enriched | Detected in many | 5 | Not detected in immune cells | Not detected | null | 7 | 2 | 6 | [
"Colon Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Colon Adenocarcinoma",
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 12,051 | 8 |
ENSG00000168079 | SCARA5 | Scavenger receptor class A member 5 | [
"Q6ZMJ2"
] | 8 | 27869883-27992673 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA024661"
] | [
"FLJ23907",
"MGC45780",
"NET33"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Ion transport",
"Iron transport",
"Transport"
] | [
"Receptor"
] | [] | [] | [] | [] | [] | null | Approved | null | null | null | null | Cluster 44: Plasmacytoid DCs - Plasma membrane proteins | Cluster 23: Choroid plexus - Mixed function | Cluster 44: Connective tissue cells - ECM organization | Cluster 108: Fibroblasts - ECM organization | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in many | null | Group enriched | Detected in some | 4 | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in some | null | Immune cell enriched | Detected in single | 121 | 0 | 0 | 0 | [] | [] | [] | 12,052 | 7 |
ENSG00000168081 | PNOC | Prepronociceptin | [
"Q13519"
] | 8 | 28316986-28343355 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA044507",
"HPA056724"
] | [
"N/OFQ",
"NOP",
"PPNOC"
] | [
"Predicted intracellular proteins",
"Predicted secreted proteins",
"Transporters"
] | [] | [
"Neuropeptide",
"Neurotransmitter",
"Opioid peptide"
] | [] | [
"Vesicles"
] | [] | [
"Secreted to blood"
] | [
"Neuropeptide"
] | Approved | Enhanced | null | 2 | null | null | Cluster 23: B-cells - Immunoglobulins | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 3: Rhabdoid - Membrane components | Cluster 44: Plasma cells - Antibody production & secretion | Cluster 18: Lymphoid tissue - Immune response | Group enriched | Detected in some | 4 | Cancer enriched | Detected in some | 11 | Group enriched | Detected in many | 7 | Cell type enhanced | Detected in some | null | Group enriched | Detected in many | 20 | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 12,053 | 5 |
ENSG00000168092 | PAFAH1B2 | Platelet activating factor acetylhydrolase 1b catalytic subunit 2 | [
"P68402"
] | 11 | 117144284-117176894 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA051836"
] | [] | [
"Cancer-related genes",
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Lipid degradation",
"Lipid metabolism"
] | [
"Hydrolase"
] | [
"Cancer-related genes"
] | [
"Cytosol"
] | [
"Nucleoli",
"Plasma membrane"
] | [] | [] | Supported | Approved | null | 11 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 26: Oligodendrocytes - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 3: Oligodendrocytes - Myelination | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 12,055 | 4 |
ENSG00000168096 | ANKS3 | Ankyrin repeat and sterile alpha motif domain containing 3 | [
"Q6ZW76"
] | 16 | 4696510-4734378 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041409",
"HPA041482"
] | [
"FLJ32345",
"FLJ32767",
"KIAA1977"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Approved | Uncertain | null | 9 | null | null | Cluster 16: Non-specific - Cell proliferation | Cluster 48: Non-specific - Mixed function | Cluster 15: Kidney cancer - Membrane components | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in many | null | 2 | 0 | 2 | [
"Glioblastoma Multiforme"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma"
] | 12,056 | 7 |
ENSG00000168101 | NUDT16L1 | Nudix hydrolase 16 like 1 | [
"Q9BRJ7"
] | 16 | 4693562-4695859 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA044186",
"HPA063605"
] | [
"SDOS",
"TIRR"
] | [
"Predicted intracellular proteins"
] | [] | [
"RNA-binding"
] | [] | [] | [] | [] | [] | null | Approved | null | 24 | null | No | Cluster 3: Non-specific - Nuclear processes | Cluster 27: Non-specific - Mixed function | Cluster 54: Non-specific - Transcription | Cluster 11: Muller glia cells - Retinal homeostasis | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,057 | 7 |
ENSG00000168118 | RAB4A | RAB4A, member RAS oncogene family | [
"P20338"
] | 1 | 229271062-229305894 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"HRES-1/RAB4",
"RAB4"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [
"Protein transport",
"Transport"
] | [
"Hydrolase"
] | [] | [] | [] | [] | [] | null | null | null | 126 | null | null | Cluster 45: Eosinophils - Unknown function | Cluster 38: Sub-cortical - Mixed function | Cluster 45: Non-specific - Nuclear processes | Cluster 97: Non-specific - Cellular respiration | Cluster 70: Non-specific - Protein processing | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Immune cell enhanced | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,059 | 8 |
ENSG00000168131 | OR2B2 | Olfactory receptor family 2 subfamily B member 2 | [
"Q9GZK3"
] | 6 | 27911185-27912396 | Evidence at transcript level | No human protein/transcript evidence | Evidence at transcript level | Evidence at transcript level | [] | [
"hs6M1-10",
"OR2B2Q",
"OR2B9",
"OR6-1"
] | [
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [
"Olfaction",
"Sensory transduction"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | null | null | null | Cluster 60: Cardiomyocytes - Cardiac muscle contraction & structure | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,061 | 9 |
ENSG00000168135 | KCNJ4 | Potassium inwardly rectifying channel subfamily J member 4 | [
"P48050"
] | 22 | 38426327-38455199 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA003270"
] | [
"HIR",
"hIRK2",
"HRK1",
"IRK3",
"Kir2.3"
] | [
"FDA approved drug targets",
"Predicted membrane proteins",
"Transporters",
"Voltage-gated ion channels"
] | [
"Ion transport",
"Potassium transport",
"Transport"
] | [
"Ion channel",
"Voltage-gated channel"
] | [
"FDA approved drug targets"
] | [
"Vesicles"
] | [] | [] | [] | Uncertain | null | null | 9 | null | null | null | Cluster 53: Neurons - Mixed function | Cluster 1: Neuronal - Visual perception | Cluster 35: Neurons - Synaptic function & neurogenesis | Cluster 78: Brain - Neuronal signaling | Group enriched | Detected in some | 18 | Cancer enhanced | Detected in some | null | Group enriched | Detected in some | 4 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,062 | 1 |
ENSG00000168137 | SETD5 | SET domain containing 5 | [
"Q9C0A6"
] | 3 | 9397615-9479240 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB017093",
"HPA035574"
] | [
"FLJ10707",
"SETD5A"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"Chromatin regulator",
"Methyltransferase",
"Transferase"
] | [
"Autism",
"Autism spectrum disorder",
"Disease variant",
"Intellectual disability"
] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Enhanced | Approved | null | 4 | null | null | Cluster 24: Non-specific - Transcription | Cluster 15: Non-specific - Transcription | Cluster 8: Non-specific - Basic cellular processes | Cluster 18: Adrenal cortex cells - Steroidogensis | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in many | null | 0 | 0 | 0 | [] | [] | [] | 12,063 | 9 |
ENSG00000168140 | VASN | Vasorin | [
"Q6EMK4"
] | 16 | 4371848-4383538 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA011246",
"HPA016992"
] | [
"SLITL2"
] | [
"Plasma proteins",
"Predicted membrane proteins",
"Predicted secreted proteins"
] | [] | [] | [] | [
"Mitochondria"
] | [
"Nucleoplasm",
"Nucleoli"
] | [
"Secreted - unknown location"
] | [
"No annotated function"
] | Approved | Uncertain | null | 45 | null | Yes | null | Cluster 39: Astrocytes - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 57: Podocytes - Glomerular filtration | Cluster 74: Non-specific - Signal transduction | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 12,064 | 4 |
ENSG00000168143 | FAM83B | Family with sequence similarity 83 member B | [
"Q5T0W9"
] | 6 | 54846771-54945099 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA031464",
"HPA031465"
] | [
"C6orf143",
"FLJ30642"
] | [
"Predicted intracellular proteins"
] | [] | [] | [
"Proto-oncogene"
] | [] | [] | [] | [] | null | Enhanced | null | 25 | null | null | null | Cluster 48: Non-specific - Mixed function | Cluster 53: Squamous epithelial cells - Keratinization | Cluster 100: Stratified epithelial cells - Barrier functions | Cluster 58: Skin - Keratinization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Lung Adenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | 12,065 | 8 |
ENSG00000168148 | H3-4 | H3.4 histone, cluster member | [
"Q16695"
] | 1 | 228424845-228425360 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB001386",
"CAB003812",
"HPA042570",
"HPA050968",
"HPA064058"
] | [
"H3.4",
"H3/g",
"H3C16",
"H3FT",
"H3t",
"HIST3H3"
] | [
"Predicted intracellular proteins"
] | [] | [
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Approved | null | 137 | null | null | null | Cluster 37: Neurons - Mixed function | Cluster 56: Non-specific - Sensory perception | null | Cluster 23: Testis - Spermatogenesis | Tissue enriched | Detected in single | 16 | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,066 | 6 |
ENSG00000168152 | THAP9 | THAP domain containing 9 | [
"Q9H5L6"
] | 4 | 82900684-82919969 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA037420",
"HPA037421"
] | [
"FLJ34093"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"DNA integration",
"DNA recombination"
] | [
"DNA-binding",
"Transferase"
] | [] | [
"Mitochondria"
] | [] | [] | [] | Approved | Uncertain | null | 1 | No | No | Cluster 14: Non-specific - Unknown function | Cluster 28: Oligodendrocytes - Mixed function | Cluster 46: Lymphoma - Humoral immune response | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,067 | 6 |
ENSG00000168158 | OR2C1 | Olfactory receptor family 2 subfamily C member 1 | [
"O95371"
] | 16 | 3355889-3357306 | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | Evidence at transcript level | [] | [
"OLFmf3",
"OR2C2P"
] | [
"G-protein coupled receptors",
"Predicted membrane proteins"
] | [
"Olfaction",
"Sensory transduction"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [] | [] | [] | [] | [] | null | null | null | null | null | null | null | Cluster 34: Non-specific - Mixed function | Cluster 51: Myeloma - Immunoglobulins | null | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,068 | 8 |
ENSG00000168159 | RNF187 | Ring finger protein 187 | [
"Q5TA31"
] | 1 | 228487382-228499899 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA030098"
] | [
"RACO-1",
"RACO1"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins"
] | [
"Ubl conjugation pathway"
] | [
"Transferase"
] | [] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 12 | Yes | No | Cluster 45: Eosinophils - Unknown function | Cluster 14: Neurons - Synaptic function | Cluster 13: Non-specific - Mixed function | Cluster 98: Neurons - Neurotransmission & signaling | Cluster 68: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,069 | 2 |
ENSG00000168172 | HOOK3 | Hook microtubule tethering protein 3 | [
"Q86VS8"
] | 8 | 42896946-43030535 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA024756"
] | [
"HK3"
] | [
"Cancer-related genes",
"Predicted intracellular proteins"
] | [
"Protein transport",
"Transport"
] | [] | [
"Cancer-related genes"
] | [
"Centriolar satellite"
] | [
"Golgi apparatus",
"Cytosol"
] | [] | [] | Supported | Approved | null | 31 | null | null | Cluster 7: Non-specific - Innate immune response | Cluster 28: Oligodendrocytes - Mixed function | Cluster 51: Myeloma - Immunoglobulins | Cluster 69: Urothelial cells - Basic cellular functions | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in many | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,070 | 4 |
ENSG00000168175 | MAPK1IP1L | Mitogen-activated protein kinase 1 interacting protein 1 like | [
"Q8NDC0"
] | 14 | 55051647-55070194 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA034506"
] | [
"C14orf32"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Approved | Uncertain | null | 24 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 21: Non-specific - Metabolism | Cluster 30: Non-specific - Gene expression regulation | Cluster 9: T-cells - Adaptive immunity: Regulation | Cluster 15: Bone marrow - Innate immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 12,071 | 1 |
ENSG00000168209 | DDIT4 | DNA damage inducible transcript 4 | [
"Q9NX09"
] | 10 | 72273919-72276036 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA034507",
"HPA034508"
] | [
"Dig2",
"FLJ20500",
"REDD-1",
"REDD1",
"RTP801"
] | [
"Predicted intracellular proteins"
] | [
"Antiviral defense",
"Apoptosis"
] | [] | [] | [
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 12 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 25: Non-specific - Transcription | Cluster 13: Non-specific - Mixed function | Cluster 85: Squamous epithelial cells - Keratinization | Cluster 54: Non-specific - Ribosome | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 4 | 2 | [] | [
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Head and Neck Squamous Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 12,072 | 1 |
ENSG00000168214 | RBPJ | Recombination signal binding protein for immunoglobulin kappa J region | [
"Q06330"
] | 4 | 26163455-26435131 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA000251",
"HPA060647"
] | [
"CBF1",
"IGKJRB",
"IGKJRB1",
"KBF2",
"RBP-J",
"RBPJK",
"RBPSUH",
"SUH"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Host-virus interaction",
"Notch signaling pathway",
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding",
"Repressor"
] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | Uncertain | null | 77 | null | null | Cluster 7: Non-specific - Innate immune response | Cluster 11: White matter - Signal transduction | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 72: Macrophages - Phagocytosis & lysosomal degradation | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe",
"Lung Adenocarcinoma"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 12,073 | 8 |
ENSG00000168216 | LMBRD1 | LMBR1 domain containing 1 | [
"Q9NUN5"
] | 6 | 69672757-69867236 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA016491",
"HPA019547"
] | [
"bA810I22.1",
"C6orf209",
"cblF",
"FLJ11240"
] | [
"Disease related genes",
"Human disease related genes",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [
"Endocytosis",
"Gastrulation",
"Host-virus interaction",
"Transport"
] | [
"Developmental protein"
] | [] | [
"Vesicles"
] | [] | [] | [] | Supported | Uncertain | null | 4 | null | null | Cluster 20: Non-specific - DNA binding | Cluster 25: Non-specific - Transcription | Cluster 28: Non-specific - Nuclear processes | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 4: Adrenal gland - Steroid metabolism | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Immune cell enhanced | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma"
] | 12,074 | 6 |
ENSG00000168228 | ZCCHC4 | Zinc finger CCHC-type containing 4 | [
"Q9H5U6"
] | 4 | 25312774-25370383 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA035575",
"HPA035576"
] | [
"FLJ23024",
"HSPC052",
"ZGRF4"
] | [
"Predicted intracellular proteins"
] | [] | [
"Methyltransferase",
"Transferase"
] | [] | [
"Nuclear speckles",
"Golgi apparatus"
] | [] | [] | [] | Approved | Uncertain | null | null | null | null | Cluster 24: Non-specific - Transcription | Cluster 28: Oligodendrocytes - Mixed function | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 7: Non-specific - Transcription | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in many | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Rectum Adenocarcinoma"
] | 12,075 | 6 |
ENSG00000168229 | PTGDR | Prostaglandin D2 receptor | [
"Q13258"
] | 14 | 52267698-52276724 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA046586",
"HPA049668"
] | [
"DP",
"DP1",
"PTGDR1"
] | [
"Disease related genes",
"FDA approved drug targets",
"G-protein coupled receptors",
"Human disease related genes",
"Predicted membrane proteins"
] | [
"Mast cell degranulation"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"Asthma",
"FDA approved drug targets"
] | [
"Plasma membrane",
"Cytosol"
] | [] | [] | [] | Approved | Enhanced | null | 5 | null | null | Cluster 15: NK-cells - Unknown function | Cluster 17: Choroid plexus - Cilium | Cluster 6: Leukemia - Signal transduction | Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity | Cluster 5: Spleen - Immune response | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in single | null | Cancer enhanced | Detected in some | null | Cell type enhanced | Detected in some | null | Group enriched | Detected in many | 6 | 0 | 0 | 0 | [] | [] | [] | 12,076 | 3 |
ENSG00000168234 | TTC39C | Tetratricopeptide repeat domain 39C | [
"Q8N584"
] | 18 | 23992773-24135610 | Evidence at protein level | Evidence at protein level | Evidence at transcript level | Evidence at protein level | [
"HPA065705",
"HPA065713"
] | [
"C18orf17",
"FLJ33761",
"HsT2697"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Approved | null | null | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 29: Forebrain - Mixed function | Cluster 35: RS4;11 - Unknown function | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 42: Retina - Visual perception | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 4 | 0 | 4 | [
"Breast Invasive Carcinoma",
"Lung Adenocarcinoma",
"Rectum Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma",
"Rectum Adenocarcinoma"
] | 12,077 | 7 |
ENSG00000168237 | GLYCTK | Glycerate kinase | [
"Q8IVS8"
] | 3 | 52287089-52295257 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA006913"
] | [
"HBEBP2",
"HBEBP4"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Kinase",
"Transferase"
] | [
"Disease variant"
] | [
"Cytosol"
] | [
"Golgi apparatus",
"Rods & Rings"
] | [] | [] | Supported | Approved | null | 49 | null | null | Cluster 22: Eosinophils - Transcription | Cluster 6: Non-specific - Immune response | Cluster 57: Stomach & Colon cancer - Digestion | Cluster 25: Hepatocytes - Plasma protein synthesis & secretion | Cluster 31: Liver - Metabolism & Coagulation | Tissue enriched | Detected in many | 7 | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in all | null | Group enriched | Detected in many | 4 | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 12,078 | 9 |
ENSG00000168243 | GNG4 | G protein subunit gamma 4 | [
"P50150"
] | 1 | 235547685-235650754 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [] | [
"Predicted intracellular proteins",
"RAS pathway related proteins"
] | [] | [
"Transducer"
] | [] | [] | [] | [] | [] | null | null | null | 6 | null | null | null | Cluster 1: Neurons - Mixed function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 59: Pituitary endocrine cells - Neuroendocrine signaling | Cluster 65: Brain - Transcription | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,079 | 3 |
ENSG00000168246 | UBTD2 | Ubiquitin domain containing 2 | [
"Q8WUN7"
] | 5 | 172209646-172283764 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA035891",
"HPA035892"
] | [
"DC-UbP",
"MGC30022"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [] | [] | [] | [] | null | Uncertain | null | 19 | null | null | null | Cluster 35: Non-specific - DNA binding | Cluster 22: Non-specific - mRNA splicing & Cell cycle | Cluster 100: Stratified epithelial cells - Barrier functions | Cluster 39: Testis - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,080 | 4 |
ENSG00000168255 | POLR2J3 | RNA polymerase II subunit J3 | [] | 7 | 102537918-102572653 | Evidence at protein level | Evidence at protein level | null | null | [
"HPA011403",
"HPA046970"
] | [] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Uncertain | null | null | null | null | Cluster 21: Neutrophils - Unknown function | Cluster 15: Non-specific - Transcription | Cluster 21: Lymphoma - Adaptive immune response | Cluster 98: Neurons - Neurotransmission & signaling | Cluster 75: Ovary - Mixed function | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 12,081 | 3 |
ENSG00000168256 | NKIRAS2 | NFKB inhibitor interacting Ras like 2 | [
"Q9NYR9"
] | 17 | 42011382-42025644 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA062861"
] | [
"DKFZP434N1526",
"kappaB-Ras2",
"KBRAS2"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Nucleoli"
] | [] | [] | [] | Approved | null | null | 1 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 16: Non-specific - Transcription | Cluster 27: Breast cancer - Unknown function | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 41: Striated muscle - Muscle contraction | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 2 | 0 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 12,082 | 3 |
ENSG00000168259 | DNAJC7 | DnaJ heat shock protein family (Hsp40) member C7 | [
"Q99615"
] | 17 | 41976421-42021376 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA023015",
"HPA052395"
] | [
"TPR2",
"TTC2"
] | [
"Predicted intracellular proteins"
] | [] | [
"Chaperone"
] | [] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Supported | Approved | null | 130 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 14: Neurons - Synaptic function | Cluster 27: Breast cancer - Unknown function | Cluster 40: Monocytes & Neutrophils - Inflammatory signaling | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 2 | 3 | [
"Glioblastoma Multiforme"
] | [
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Liver Hepatocellular Carcinoma",
"Ovary Serous Cystadenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 12,083 | 5 |
ENSG00000168263 | KCNV2 | Potassium voltage-gated channel modifier subfamily V member 2 | [
"Q8TDN2"
] | 9 | 2717510-2730037 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA031131"
] | [
"Kv8.2"
] | [
"Disease related genes",
"Human disease related genes",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters",
"Voltage-gated ion channels"
] | [
"Ion transport",
"Potassium transport",
"Transport"
] | [
"Ion channel",
"Potassium channel",
"Voltage-gated channel"
] | [
"Cone-rod dystrophy",
"Disease variant"
] | [] | [] | [] | [] | null | Enhanced | null | 2 | null | null | null | Cluster 33: Neurons - Mixed function | Cluster 1: Neuronal - Visual perception | Cluster 79: Photoreceptor cells - Phototransduction | Cluster 42: Retina - Visual perception | Tissue enriched | Detected in some | 59 | Not detected | Not detected | null | Cancer enriched | Detected in single | 90 | Group enriched | Detected in many | 5 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,084 | 6 |
ENSG00000168264 | IRF2BP2 | Interferon regulatory factor 2 binding protein 2 | [
"Q7Z5L9"
] | 1 | 234604269-234610178 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA027815",
"HPA062269"
] | [
"IRF-2BP2"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Repressor"
] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [] | [] | [] | Enhanced | Approved | null | 15 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 13: Oligodendrocytes - Mixed function | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 15: Bone marrow - Innate immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 2 | 0 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,085 | 2 |
ENSG00000168267 | PTF1A | Pancreas associated transcription factor 1a | [
"Q7RTS3"
] | 10 | 23192312-23194245 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"CAB022612",
"HPA073033"
] | [
"bHLHa29",
"p48",
"PTF1-p48"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Differentiation",
"Neurogenesis",
"Transcription",
"Transcription regulation"
] | [
"Developmental protein",
"DNA-binding"
] | [
"Diabetes mellitus"
] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | null | null | 2 | null | null | null | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 10: Ciliated cells - Ion channel activity | Cluster 5: Pancreatic acinar cells - Pancreatic exocrine secretion | Cluster 8: Pancreas - Proteolysis | Tissue enriched | Detected in some | 47 | Cancer enhanced | Detected in single | null | Cancer enhanced | Detected in some | null | Cell type enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,086 | 7 |
ENSG00000168268 | NT5DC2 | 5'-nucleotidase domain containing 2 | [
"Q9H857"
] | 3 | 52524385-52535054 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA050683"
] | [
"FLJ12442"
] | [
"Predicted intracellular proteins"
] | [] | [
"Hydrolase"
] | [] | [] | [] | [] | [] | null | Approved | null | 6 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 8: Non-specific - Basic cellular processes | Cluster 110: Mural cells - ECM organization | Cluster 35: Non-specific - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in single | null | 1 | 0 | 1 | [] | [
"Liver Hepatocellular Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | 12,087 | 5 |
ENSG00000168269 | FOXI1 | Forkhead box I1 | [
"Q12951"
] | 5 | 170105897-170109734 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA071469"
] | [
"FKHL10",
"FREAC6"
] | [
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding"
] | [] | [
"Nucleoli"
] | [
"Vesicles"
] | [] | [] | Supported | Enhanced | null | 1 | null | null | null | Cluster 43: Hindbrain - Mixed function | Cluster 24: Non-specific - Unknown function | Cluster 50: Renal epithelial cells - Ion transport and pH regulation | Cluster 72: Kidney - Transmembrane transport | Tissue enhanced | Detected in some | null | Cancer enhanced | Detected in some | null | Cancer enriched | Detected in many | 40 | Group enriched | Detected in some | 10 | Immune cell enriched | Detected in single | 16 | 0 | 0 | 0 | [] | [] | [] | 12,088 | 9 |
ENSG00000168273 | SMIM4 | Small integral membrane protein 4 | [
"Q8WVI0"
] | 3 | 52534013-52579237 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA047771"
] | [
"C3orf78"
] | [
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [] | [] | [] | [
"Nucleoplasm",
"Mitochondria"
] | [] | [] | [] | Approved | Uncertain | null | null | null | null | Cluster 18: Non-specific - Translation | Cluster 55: Non-specific - Transcription | Cluster 8: Non-specific - Basic cellular processes | Cluster 97: Non-specific - Cellular respiration | Cluster 4: Adrenal gland - Steroid metabolism | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | [] | [
"Kidney Renal Papillary Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 12,089 | 2 |
ENSG00000168275 | COA6 | Cytochrome c oxidase assembly factor 6 | [
"Q5JTJ3"
] | 1 | 234373456-234385080 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA028588"
] | [
"C1orf31"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Disease variant",
"Primary mitochondrial disease"
] | [
"Mitochondria"
] | [
"Nucleoplasm"
] | [] | [] | Supported | Approved | null | 3 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 14: Neurons - Synaptic function | Cluster 7: Liver cancer - Metabolism | Cluster 97: Non-specific - Cellular respiration | Cluster 25: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [] | [
"Glioblastoma Multiforme",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Lung Adenocarcinoma"
] | [
"Glioblastoma Multiforme",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Lung Adenocarcinoma"
] | 12,090 | 5 |
ENSG00000168282 | MGAT2 | Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | [
"Q10469"
] | 14 | 49620799-49623481 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA043721",
"HPA056824"
] | [
"GNT-II"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [] | [
"Glycosyltransferase",
"Transferase"
] | [
"Congenital disorder of glycosylation",
"Disease variant"
] | [
"Golgi apparatus"
] | [] | [] | [] | Supported | Approved | null | 6 | null | Yes | Cluster 10: Non-specific - Membrane trafficking | Cluster 41: Monoamines - Neurotransmitter signalling | Cluster 30: Non-specific - Gene expression regulation | Cluster 108: Fibroblasts - ECM organization | Cluster 57: Testis - Spermatogenesis | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,092 | 6 |
ENSG00000168286 | THAP11 | THAP domain containing 11 | [
"Q96EK4"
] | 16 | 67842320-67844195 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041434",
"HPA042189",
"HPA072537"
] | [
"CTG-B43a",
"CTG-B45d",
"HRIHFB2206",
"RONIN"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding",
"Repressor"
] | [
"Disease variant",
"Epilepsy",
"Intellectual disability",
"Neurodegeneration",
"Spinocerebellar ataxia"
] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Supported | Supported | null | 16 | null | No | Cluster 33: Non-specific - ATP binding | Cluster 27: Non-specific - Mixed function | Cluster 68: Non-specific - Cell cycle regulation | Cluster 97: Non-specific - Cellular respiration | Cluster 24: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,094 | 7 |
ENSG00000168288 | MMADHC | Metabolism of cobalamin associated D | [
"Q9H3L0"
] | 2 | 149569637-149587778 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA037531",
"HPA037532"
] | [
"C2orf25",
"cblD",
"CL25022"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Disease variant"
] | [] | [] | [] | [] | null | Supported | null | 7 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 21: Non-specific - Metabolism | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 63: Non-specific - Basic cellular processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Chromophobe"
] | [
"Kidney Chromophobe",
"Kidney Renal Clear Cell Carcinoma"
] | 12,095 | 1 |
ENSG00000168291 | PDHB | Pyruvate dehydrogenase E1 subunit beta | [
"P11177"
] | 3 | 58427630-58433857 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB033794",
"HPA036744",
"HPA036745"
] | [
"E1beta",
"PDHE1B"
] | [
"Citric acid cycle related proteins",
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Carbohydrate metabolism",
"Glucose metabolism",
"Tricarboxylic acid cycle"
] | [
"Oxidoreductase"
] | [
"Disease variant"
] | [
"Mitochondria"
] | [
"Nucleoplasm",
"Cell Junctions"
] | [] | [] | Supported | Enhanced | null | 40 | No | No | Cluster 12: Non-specific - Mitochondrial translation | Cluster 21: Non-specific - Metabolism | Cluster 8: Non-specific - Basic cellular processes | Cluster 97: Non-specific - Cellular respiration | Cluster 52: Non-specific - Cellular respiration | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma"
] | 12,096 | 9 |
ENSG00000168297 | PXK | PX domain containing serine/threonine kinase like | [
"Q7Z7A4"
] | 3 | 58332880-58426127 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA024068"
] | [
"FLJ20335",
"Slob"
] | [
"Enzymes",
"Predicted intracellular proteins"
] | [] | [
"Actin-binding"
] | [] | [
"Cytosol"
] | [
"Plasma membrane",
"Centriolar satellite"
] | [] | [] | Supported | Supported | null | 3 | null | null | Cluster 2: Dendritic cells - Unknown function | Cluster 28: Oligodendrocytes - Mixed function | Cluster 14: Myeloid leukemia - Innate immune response | Cluster 80: Oligodendrocytes - Myelination | Cluster 3: Oligodendrocytes - Myelination | Tissue enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 12,097 | 2 |
ENSG00000168298 | H1-4 | H1.4 linker histone, cluster member | [
"P10412"
] | 6 | 26156329-26157115 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB011506",
"HPA055907"
] | [
"H1.4",
"H1e",
"H1F4",
"H1s-4",
"HIST1H1E"
] | [
"Disease related genes",
"Predicted intracellular proteins"
] | [] | [
"DNA-binding"
] | [
"Intellectual disability"
] | [
"Nuclear speckles"
] | [
"Cytosol"
] | [] | [] | Supported | Supported | null | 251 | null | Yes | Cluster 32: Basophils - Transcription | Cluster 2: Neurons - Nucleosome | Cluster 41: Non-specific - Nucleosome assembly | Cluster 66: Erythroid cells - Erythroid differentiation and maturation | Cluster 15: Bone marrow - Innate immune response | Tissue enriched | Detected in many | 8 | Low cancer specificity | Detected in many | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 12,098 | 6 |
ENSG00000168301 | KCTD6 | Potassium channel tetramerization domain containing 6 | [
"Q8NC69"
] | 3 | 58492096-58502360 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA036100",
"HPA036101"
] | [
"KCASH3",
"MGC27385"
] | [
"Predicted intracellular proteins"
] | [
"Growth regulation",
"Ubl conjugation pathway"
] | [] | [
"Tumor suppressor"
] | [
"Nucleoli",
"Mitochondria"
] | [] | [] | [] | Approved | Uncertain | null | 40 | null | null | Cluster 41: Basophils - Unknown function | Cluster 34: Non-specific - Mixed function | Cluster 8: Non-specific - Basic cellular processes | Cluster 109: Neurons - Neuronal signaling | Cluster 46: Brain & retina - Neuronal signaling | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,100 | 7 |
ENSG00000168303 | MPLKIP | M-phase specific PLK1 interacting protein | [
"Q8TAP9"
] | 7 | 40126027-40134622 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA058457",
"HPA065463"
] | [
"C7orf11",
"ORF20",
"TTDN1"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Mitosis"
] | [] | [
"Disease variant"
] | [
"Nucleoplasm"
] | [
"Golgi apparatus",
"Vesicles"
] | [] | [] | Supported | Uncertain | null | 8 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 48: Non-specific - Mixed function | Cluster 67: Non-specific - Unknown function | Cluster 97: Non-specific - Cellular respiration | Cluster 31: Liver - Metabolism & Coagulation | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 1 | 0 | 1 | [] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme"
] | 12,101 | 9 |
ENSG00000168306 | ACOX2 | Acyl-CoA oxidase 2 | [
"Q99424"
] | 3 | 58505136-58537283 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA038280",
"HPA064845"
] | [
"BRCACOX",
"BRCOX",
"THCCox"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Fatty acid metabolism",
"Lipid metabolism"
] | [
"Oxidoreductase"
] | [
"Disease variant"
] | [
"Vesicles"
] | [
"Cytosol"
] | [] | [] | Approved | Enhanced | null | 2 | No | No | null | Cluster 36: Choroid plexus - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 93: Hepatocytes - Bile production & excretion | Cluster 16: Liver & Kidney - Metabolism | Tissue enriched | Detected in many | 4 | Cancer enhanced | Detected in some | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 12,102 | 7 |
ENSG00000168309 | FAM107A | Family with sequence similarity 107 member A | [
"O95990"
] | 3 | 58564117-58627610 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA055888"
] | [
"DRR1",
"TU3A"
] | [
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Growth regulation",
"Stress response"
] | [
"Actin-binding"
] | [] | [
"Nuclear speckles"
] | [] | [] | [] | Supported | Enhanced | null | 8 | null | null | null | Cluster 40: Astrocytes - Astrocyte-neuron interactions | Cluster 15: Kidney cancer - Membrane components | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 3: Oligodendrocytes - Myelination | Group enriched | Detected in many | 5 | Cancer enhanced | Detected in some | null | Cancer enriched | Detected in all | 7 | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Glioblastoma Multiforme"
] | [
"Glioblastoma Multiforme",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,103 | 6 |
ENSG00000168310 | IRF2 | Interferon regulatory factor 2 | [
"P14316"
] | 4 | 184385702-184474558 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA030813",
"CAB032306",
"HPA057327"
] | [] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"DNA-binding",
"Repressor"
] | [] | [
"Nucleoplasm"
] | [
"Cell Junctions",
"Cytosol"
] | [] | [] | Enhanced | Supported | null | 24 | null | null | Cluster 35: Neutrophils - Protein binding | Cluster 25: Non-specific - Transcription | Cluster 55: Lymphoma - Immune response | Cluster 24: Neutrophils - Innate immunity signal integration | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 12,104 | 2 |
ENSG00000168314 | MOBP | Myelin associated oligodendrocyte basic protein | [
"Q13875"
] | 3 | 39467198-39529479 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA035152"
] | [] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Cytoplasmic bodies"
] | [] | [] | [] | Supported | Enhanced | null | 5 | null | null | null | Cluster 30: White matter - Myelination | Cluster 66: Non-specific - Mitochondria | Cluster 80: Oligodendrocytes - Myelination | Cluster 3: Oligodendrocytes - Myelination | Tissue enriched | Detected in some | 18 | Cancer enhanced | Detected in single | null | Cancer enriched | Detected in single | 30 | Cell type enriched | Detected in some | 12 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,105 | 1 |
ENSG00000168329 | CX3CR1 | C-X3-C motif chemokine receptor 1 | [
"P49238"
] | 3 | 39263495-39281735 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB032478",
"HPA046587"
] | [
"CCRL1",
"CMKBRL1",
"CMKDR1",
"GPR13",
"V28"
] | [
"Disease related genes",
"G-protein coupled receptors",
"Human disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted membrane proteins"
] | [
"Adaptive immunity",
"Host-virus interaction",
"Immunity",
"Inflammatory response",
"Innate immunity"
] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"Age-related macular degeneration"
] | [
"Plasma membrane"
] | [] | [] | [] | Supported | Approved | null | null | null | null | Cluster 37: Monocytes & Neutrophils - Innate immune response | Cluster 20: Macrophages & Microglia - Immune response | Cluster 51: Myeloma - Immunoglobulins | Cluster 74: Microglia - Neuroimmunity & neuroinflammation | Cluster 73: Brain - Neuronal signaling | Tissue enhanced | Detected in many | null | Cancer enriched | Detected in some | 6 | Group enriched | Detected in many | 4 | Cell type enriched | Detected in some | 8 | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [
"Kidney Renal Clear Cell Carcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma"
] | 12,106 | 1 |
ENSG00000168334 | XIRP1 | Xin actin binding repeat containing 1 | [
"Q702N8"
] | 3 | 39183210-39192596 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA016750",
"HPA018458",
"CAB026391"
] | [
"CMYA1",
"DKFZp451D042",
"Xin"
] | [
"Predicted intracellular proteins"
] | [] | [
"Actin-binding"
] | [] | [
"Actin filaments"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Enhanced | null | 8 | null | null | null | Cluster 25: Non-specific - Transcription | Cluster 33: Sarcoma - Muscle contraction | Cluster 60: Cardiomyocytes - Cardiac muscle contraction & structure | Cluster 41: Striated muscle - Muscle contraction | Group enriched | Detected in many | 5 | Not detected | Not detected | null | Cancer enhanced | Detected in some | null | Group enriched | Detected in some | 5 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,108 | 9 |
ENSG00000168348 | INSM2 | INSM transcriptional repressor 2 | [
"Q96T92"
] | 14 | 35534164-35537054 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA044885",
"HPA051925"
] | [
"IA-6",
"Mlt1"
] | [
"Predicted intracellular proteins",
"Transcription factors"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding"
] | [] | [
"Nucleoplasm"
] | [] | [] | [] | Approved | Uncertain | null | null | null | null | null | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 17: Neuroblastoma - Neuronal signaling | Cluster 82: Dendritic cells - Antigen presentation | Cluster 46: Brain & retina - Neuronal signaling | Tissue enhanced | Detected in some | null | Cancer enriched | Detected in some | 18 | Not detected | Not detected | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Glioblastoma Multiforme"
] | [] | [
"Glioblastoma Multiforme"
] | 12,109 | 7 |
ENSG00000168350 | DEGS2 | Delta 4-desaturase, sphingolipid 2 | [
"Q6QHC5"
] | 14 | 100143957-100159645 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA046644"
] | [
"C14orf66",
"DES2",
"FADS8"
] | [
"Enzymes",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins"
] | [
"Lipid biosynthesis",
"Lipid metabolism"
] | [
"Oxidoreductase"
] | [] | [
"Nucleoplasm",
"Nucleoli"
] | [] | [] | [] | Approved | null | null | null | null | null | Cluster 22: Eosinophils - Transcription | Cluster 15: Non-specific - Transcription | Cluster 27: Breast cancer - Unknown function | Cluster 85: Squamous epithelial cells - Keratinization | Cluster 77: Intestine - Digestion | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 4 | 2 | 2 | 1 | [
"Kidney Renal Clear Cell Carcinoma",
"Stomach Adenocarcinoma"
] | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Stomach Adenocarcinoma"
] | 12,110 | 6 |
ENSG00000168356 | SCN11A | Sodium voltage-gated channel alpha subunit 11 | [
"Q9UI33"
] | 3 | 38845764-39052157 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA036746",
"HPA036747"
] | [
"NaN",
"Nav1.9",
"SCN12A",
"SNS-2"
] | [
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Metabolic proteins",
"Predicted membrane proteins",
"Transporters",
"Voltage-gated ion channels"
] | [
"Ion transport",
"Sodium transport",
"Transport"
] | [
"Ion channel",
"Sodium channel",
"Voltage-gated channel"
] | [
"Disease variant",
"FDA approved drug targets",
"Neurodegeneration",
"Neuropathy"
] | [] | [] | [] | [] | null | Uncertain | null | null | null | null | null | Cluster 39: Astrocytes - Mixed function | Cluster 21: Lymphoma - Adaptive immune response | Cluster 82: Dendritic cells - Antigen presentation | Cluster 5: Spleen - Immune response | Tissue enhanced | Detected in some | null | Not detected | Not detected | null | Not detected | Not detected | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,111 | 7 |
ENSG00000168374 | ARF4 | ADP ribosylation factor 4 | [
"P18085"
] | 3 | 57571363-57598220 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"ARF2"
] | [
"Essential proteins",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"ER-Golgi transport",
"Protein transport",
"Transport"
] | [] | [] | [] | [] | [] | [] | null | null | null | 41 | null | null | Cluster 10: Non-specific - Membrane trafficking | Cluster 21: Non-specific - Metabolism | Cluster 8: Non-specific - Basic cellular processes | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 22: Epididymis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 2 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Thyroid Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Thyroid Carcinoma"
] | 12,112 | 2 |
ENSG00000168385 | SEPTIN2 | Septin 2 | [
"Q15019"
] | 2 | 241315100-241354027 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB017190",
"HPA018481",
"HPA063623"
] | [
"DIFF6",
"hNedd5",
"KIAA0158",
"NEDD5",
"Pnutl3",
"SEPT2"
] | [
"Cancer-related genes",
"Plasma proteins",
"Predicted intracellular proteins"
] | [
"Cell cycle",
"Cell division",
"Differentiation",
"Mitosis",
"Spermatogenesis"
] | [] | [
"Cancer-related genes"
] | [
"Actin filaments"
] | [
"Plasma membrane",
"Microtubules",
"Cytokinetic bridge",
"Primary cilium",
"Principal piece",
"Annulus"
] | [] | [] | Supported | Supported | null | 51 | Yes | No | Cluster 10: Non-specific - Membrane trafficking | Cluster 28: Oligodendrocytes - Mixed function | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 8: Non-specific - Secretory pathway | Cluster 55: Breast - Lactation | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 4 | 0 | 4 | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | [
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,113 | 7 |
ENSG00000168386 | FILIP1L | Filamin A interacting protein 1 like | [
"Q4L180"
] | 3 | 99828811-100114513 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA043133"
] | [
"DOC-1",
"GIP130"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Plasma membrane"
] | [] | [] | [] | Approved | Approved | null | null | null | null | Cluster 40: Monocytes - Innate immune response | Cluster 24: Neurons - Mixed function | Cluster 64: Connective tissue cells - ECM organization | Cluster 36: Skeletal myocytes - Muscle excitation & contraction | Cluster 12: Smooth muscle tissue - ECM organization | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in some | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Ovary Serous Cystadenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Ovary Serous Cystadenocarcinoma"
] | 12,114 | 1 |
ENSG00000168389 | MFSD2A | Major facilitator superfamily domain containing 2A | [
"Q8NA29"
] | 1 | 39955112-39969968 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA043107"
] | [
"FLJ14490",
"MFSD2",
"SLC59A1"
] | [
"Disease related genes",
"Human disease related genes",
"Potential drug targets",
"Predicted membrane proteins",
"Transporters"
] | [
"Lipid transport",
"Symport",
"Transport"
] | [] | [
"Disease variant",
"Primary microcephaly"
] | [
"Plasma membrane",
"Cytosol"
] | [
"Cytoplasmic bodies"
] | [] | [] | Approved | Uncertain | null | null | null | null | Cluster 2: Dendritic cells - Unknown function | Cluster 47: Endothelial cells - Vasculature | Cluster 10: Ciliated cells - Ion channel activity | Cluster 93: Hepatocytes - Bile production & excretion | Cluster 31: Liver - Metabolism & Coagulation | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Group enriched | Detected in many | 10 | 2 | 0 | 2 | [
"Colon Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Colon Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma"
] | 12,115 | 6 |
ENSG00000168393 | DTYMK | Deoxythymidylate kinase | [
"P23919"
] | 2 | 241675747-241686944 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA042593",
"HPA042719"
] | [
"CDC8",
"TMPK",
"TYMK"
] | [
"Disease related genes",
"Enzymes",
"Essential proteins",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Nucleotide biosynthesis"
] | [
"Kinase",
"Transferase"
] | [
"Disease variant",
"Intellectual disability",
"Neurodegeneration"
] | [
"Mitochondria"
] | [] | [] | [] | Approved | Approved | null | 6 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 6: Non-specific - Immune response | Cluster 35: RS4;11 - Unknown function | Cluster 27: Non-specific - Cell proliferation | Cluster 44: Bone marrow - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 4 | 1 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma"
] | 12,116 | 4 |
ENSG00000168394 | TAP1 | Transporter 1, ATP binding cassette subfamily B member | [
"Q03518"
] | 6 | 32845209-32853816 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB009516",
"HPA072354"
] | [
"ABCB2",
"D6S114E",
"PSF1",
"RING4"
] | [
"Cancer-related genes",
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Plasma proteins",
"Potential drug targets",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Adaptive immunity",
"Host-virus interaction",
"Immunity",
"Peptide transport",
"Protein transport",
"Transport"
] | [
"Translocase"
] | [
"Cancer-related genes"
] | [
"Endoplasmic reticulum",
"Centriolar satellite"
] | [] | [] | [] | Approved | Approved | null | 55 | null | null | Cluster 42: Non-specific - Vesicular transport | Cluster 43: Hindbrain - Mixed function | Cluster 31: Non-specific - Antiviral immune response | Cluster 102: Non-specific - Mixed function | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in some | null | Low immune cell specificity | Detected in all | null | 0 | 0 | 0 | [] | [] | [] | 12,117 | 4 |
ENSG00000168395 | ING5 | Inhibitor of growth family member 5 | [
"Q8WYH8"
] | 2 | 241687085-241729478 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA042685"
] | [
"FLJ23842",
"p28ING5"
] | [
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"Activator",
"Chromatin regulator"
] | [] | [] | [] | [] | [] | null | Approved | null | 50 | null | null | Cluster 22: Eosinophils - Transcription | Cluster 48: Non-specific - Mixed function | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 89: Adipocytes - Lipid metabolism | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Immune cell enhanced | Detected in all | null | 4 | 0 | 4 | [
"Bladder Urothelial Carcinoma",
"Breast Invasive Carcinoma",
"Lung Squamous Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma"
] | [
"Bladder Urothelial Carcinoma",
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Squamous Cell Carcinoma"
] | 12,118 | 3 |
ENSG00000168397 | ATG4B | Autophagy related 4B cysteine peptidase | [
"Q9Y4P1"
] | 2 | 241637213-241673857 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB037195",
"HPA069803"
] | [
"APG4B",
"AUTL1",
"DKFZp586D1822",
"KIAA0943"
] | [
"Enzymes",
"Predicted intracellular proteins",
"Transporters"
] | [
"Autophagy",
"Protein transport",
"Transport",
"Ubl conjugation pathway"
] | [
"Hydrolase",
"Protease",
"Thiol protease"
] | [] | [
"Nucleoplasm",
"Cytosol"
] | [] | [] | [] | Approved | Approved | null | 77 | null | null | Cluster 13: Non-specific - Mitochondria | Cluster 52: Neurons & Synapses - Synaptic function | Cluster 26: Non-specific - Mitochondria & RNA binding | Cluster 29: Neutrophils - Innate immune cellular maintenance | Cluster 64: Non-specific - Transcription | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 12,119 | 3 |
ENSG00000168404 | MLKL | Mixed lineage kinase domain like pseudokinase | [
"Q8NB16"
] | 16 | 74671855-74700960 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA078638"
] | [
"FLJ34389"
] | [
"Enzymes",
"Predicted intracellular proteins",
"Transporters"
] | [
"Necrosis"
] | [] | [] | [
"Plasma membrane"
] | [
"Cell Junctions",
"Cytosol"
] | [] | [] | Supported | null | null | 4 | null | null | Cluster 38: Monocytes & Neutrophils - Degranulation | Cluster 47: Endothelial cells - Vasculature | Cluster 71: Lymphoma - Inflammatory response | Cluster 32: Endothelial cells - Angiogenesis & vascular immunity | Cluster 66: Lymphoid tissue - Immune response | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Breast Invasive Carcinoma"
] | [
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 12,121 | 6 |
ENSG00000168411 | RFWD3 | Ring finger and WD repeat domain 3 | [
"Q6PCD5"
] | 16 | 74621399-74666877 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA048258",
"HPA075649"
] | [
"FANCW",
"FLJ10520",
"RNF201"
] | [
"Disease related genes",
"Enzymes",
"Essential proteins",
"Human disease related genes",
"Metabolic proteins",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"DNA damage",
"DNA repair",
"Ubl conjugation pathway"
] | [
"Transferase"
] | [
"Disease variant",
"Fanconi anemia"
] | [
"Nucleoplasm"
] | [
"Cytosol"
] | [] | [] | Enhanced | Approved | null | 39 | No | No | Cluster 15: NK-cells - Unknown function | Cluster 50: Non-specific - Nucleic acid binding | Cluster 68: Non-specific - Cell cycle regulation | Cluster 27: Non-specific - Cell proliferation | Cluster 44: Bone marrow - Nuclear processes | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 12,122 | 4 |
ENSG00000168412 | MTNR1A | Melatonin receptor 1A | [
"P48039"
] | 4 | 186526792-186555567 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [] | [
"MEL-1A-R"
] | [
"FDA approved drug targets",
"G-protein coupled receptors",
"Predicted membrane proteins",
"Transporters"
] | [] | [
"G-protein coupled receptor",
"Receptor",
"Transducer"
] | [
"FDA approved drug targets"
] | [] | [] | [] | [] | null | null | null | 26 | null | null | null | Cluster 10: Cerebellum - Nucleic acid binding | Cluster 12: Bone cancer - Neuronal signaling | Cluster 53: Late primary spermatocytes - Meiotic division & transition | Cluster 26: Kidney & Intestine - Metabolism | Tissue enhanced | Detected in single | null | Cancer enhanced | Detected in single | null | Not detected | Not detected | null | Not detected | Not detected | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,123 | 4 |
ENSG00000168418 | KCNG4 | Potassium voltage-gated channel modifier subfamily G member 4 | [
"Q8TDN1"
] | 16 | 84218657-84240012 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA063516"
] | [
"Kv6.4"
] | [
"Predicted membrane proteins",
"Transporters",
"Voltage-gated ion channels"
] | [
"Ion transport",
"Potassium transport",
"Transport"
] | [
"Ion channel",
"Potassium channel",
"Voltage-gated channel"
] | [] | [
"Plasma membrane"
] | [
"Nucleoplasm"
] | [] | [] | Supported | null | null | 2 | null | null | null | Cluster 43: Hindbrain - Mixed function | Cluster 1: Neuronal - Visual perception | Cluster 86: Retinal bipolar cells - Synaptic signal transduction | Cluster 46: Brain & retina - Neuronal signaling | Tissue enriched | Detected in single | 6 | Not detected | Not detected | null | Not detected | Not detected | null | Cell type enriched | Detected in some | 6 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,124 | 8 |
ENSG00000168421 | RHOH | Ras homolog family member H | [
"Q15669"
] | 4 | 40191011-40246967 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA030345",
"HPA061314"
] | [
"ARHH",
"TTF"
] | [
"Cancer-related genes",
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [] | [] | [
"Cancer-related genes",
"Disease variant"
] | [
"Golgi apparatus",
"Vesicles"
] | [] | [] | [] | Approved | Uncertain | null | 15 | null | null | Cluster 3: Non-specific - Nuclear processes | Cluster 39: Astrocytes - Mixed function | Cluster 59: Leukemia - T-cell receptor | Cluster 87: B-cells - Adaptive immunity: Humoral response | Cluster 51: Lymphoid tissue - Adaptive immune response | Group enriched | Detected in many | 7 | Group enriched | Detected in many | 6 | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Lung Adenocarcinoma",
"Skin Cutaneous Melanoma"
] | [] | [
"Lung Adenocarcinoma",
"Skin Cutaneous Melanoma"
] | 12,125 | 1 |
ENSG00000168427 | KLHL30 | Kelch like family member 30 | [
"Q0D2K2"
] | 2 | 238138668-238152947 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [
"HPA062095"
] | [
"FLJ43374"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Centriolar satellite"
] | [] | [] | [] | Approved | null | null | null | null | null | null | Cluster 44: Non-specific - Mixed function | Cluster 33: Sarcoma - Muscle contraction | Cluster 46: Skeletal myocytes - Muscle structure & formation | Cluster 19: Skeletal muscle - Striated muscle contraction | Tissue enriched | Detected in many | 10 | Cancer enhanced | Detected in some | null | Low cancer specificity | Detected in some | null | Group enriched | Detected in some | 4 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,126 | 8 |
ENSG00000168434 | COG7 | Component of oligomeric golgi complex 7 | [
"P83436"
] | 16 | 23388493-23453189 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA040758",
"HPA041824",
"HPA064645"
] | [] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"Protein transport",
"Transport"
] | [] | [
"Congenital disorder of glycosylation"
] | [
"Golgi apparatus"
] | [] | [] | [] | Supported | Uncertain | null | 30 | null | null | Cluster 5: Non-specific - Cell proliferation | Cluster 36: Choroid plexus - Mixed function | Cluster 54: Non-specific - Transcription | Cluster 59: Pituitary endocrine cells - Neuroendocrine signaling | Cluster 20: Pituitary gland - Hormone signaling | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Pancreatic Adenocarcinoma"
] | 12,127 | 7 |
ENSG00000168438 | CDC40 | Cell division cycle 40 | [
"O60508"
] | 6 | 110180141-110254275 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA046620"
] | [
"EHB3",
"FLJ10564",
"PRP17",
"PRPF17"
] | [
"Disease related genes",
"Essential proteins",
"Human disease related genes",
"Predicted intracellular proteins"
] | [
"mRNA processing",
"mRNA splicing"
] | [] | [
"Disease variant",
"Intellectual disability"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | null | null | 59 | null | null | Cluster 32: Basophils - Transcription | Cluster 34: Non-specific - Mixed function | Cluster 28: Non-specific - Nuclear processes | Cluster 60: Cardiomyocytes - Cardiac muscle contraction & structure | Cluster 44: Bone marrow - Nuclear processes | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 3 | 0 | 3 | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Breast Invasive Carcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,128 | 6 |
ENSG00000168439 | STIP1 | Stress induced phosphoprotein 1 | [
"P31948"
] | 11 | 64185272-64204543 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB017448",
"HPA039291",
"HPA044062"
] | [
"HOP",
"STI1"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Plasma membrane",
"Cytosol"
] | [
"Nucleoplasm"
] | [] | [] | Approved | Enhanced | null | 148 | null | null | Cluster 12: Non-specific - Mitochondrial translation | Cluster 55: Non-specific - Transcription | Cluster 24: Non-specific - Unknown function | Cluster 75: Non-specific - Chaperones and protein folding | Cluster 67: Testis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in all | null | Low immune cell specificity | Detected in all | null | 7 | 2 | 6 | [] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Chromophobe",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Head and Neck Squamous Cell Carcinoma",
"Kidney Chromophobe",
"Kidney Renal Papillary Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Lung Adenocarcinoma",
"Pancreatic Adenocarcinoma"
] | 12,129 | 3 |
ENSG00000168447 | SCNN1B | Sodium channel epithelial 1 subunit beta | [
"P51168"
] | 16 | 23278231-23381294 | Evidence at protein level | Evidence at transcript level | Evidence at protein level | Evidence at protein level | [
"HPA015612"
] | [
"ENaCbeta"
] | [
"Disease related genes",
"FDA approved drug targets",
"Human disease related genes",
"Metabolic proteins",
"Predicted intracellular proteins",
"Predicted membrane proteins",
"Transporters"
] | [
"Ion transport",
"Sodium transport",
"Transport"
] | [
"Ion channel",
"Sodium channel"
] | [
"Disease variant",
"FDA approved drug targets"
] | [] | [] | [] | [] | null | Uncertain | null | 11 | null | null | null | Cluster 35: Non-specific - DNA binding | Cluster 54: Non-specific - Transcription | Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier | Cluster 11: Esophagus - Basic cellular processes | Tissue enhanced | Detected in many | null | Group enriched | Detected in many | 7 | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Lung Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma"
] | [
"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma",
"Kidney Renal Clear Cell Carcinoma",
"Lung Adenocarcinoma"
] | 12,130 | 5 |
ENSG00000168453 | HR | HR lysine demethylase and nuclear receptor corepressor | [
"O43593"
] | 8 | 22114419-22133384 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA054888"
] | [
"ALUNC",
"AU"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Potential drug targets",
"Predicted intracellular proteins"
] | [
"Transcription",
"Transcription regulation"
] | [
"DNA-binding",
"Oxidoreductase"
] | [
"Disease variant",
"Hypotrichosis"
] | [
"Nucleoplasm"
] | [] | [] | [] | Supported | null | null | 18 | null | null | null | Cluster 37: Neurons - Mixed function | Cluster 1: Neuronal - Visual perception | Cluster 86: Retinal bipolar cells - Synaptic signal transduction | Cluster 2: Non-specific - Mixed function | Tissue enhanced | Detected in many | null | Cancer enhanced | Detected in many | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,131 | 2 |
ENSG00000168454 | TXNDC2 | Thioredoxin domain containing 2 | [
"Q86VQ3"
] | 18 | 9885766-9889275 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"CAB016414",
"HPA018817"
] | [
"SPTRX1"
] | [
"Predicted intracellular proteins"
] | [
"Differentiation",
"Spermatogenesis"
] | [
"Developmental protein"
] | [] | [] | [] | [] | [] | null | Enhanced | null | 1 | null | null | null | null | Cluster 72: Neuronal - Signal transduction | Cluster 42: Early spermatids - Spermiogenesis: Acrosomal phase | Cluster 6: Testis - Spermatogenesis | Tissue enriched | Detected in single | 313 | Not detected | Not detected | null | Not detected | Not detected | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,132 | 6 |
ENSG00000168461 | RAB31 | RAB31, member RAS oncogene family | [
"Q13636"
] | 18 | 9708275-9862551 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA019717",
"HPA074046"
] | [
"Rab22B"
] | [
"Predicted intracellular proteins"
] | [] | [
"Hydrolase"
] | [] | [
"Golgi apparatus",
"Vesicles"
] | [] | [] | [] | Supported | Approved | null | 15 | null | null | Cluster 32: Basophils - Transcription | Cluster 19: Astrocytes - Mixed function | Cluster 72: Neuronal - Signal transduction | Cluster 37: Neutrophil progenitors - Granulopoiesis | Cluster 73: Brain - Neuronal signaling | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cancer enhanced | Detected in all | null | Cell type enhanced | Detected in many | null | Immune cell enhanced | Detected in many | null | 1 | 0 | 1 | [] | [
"Stomach Adenocarcinoma"
] | [
"Stomach Adenocarcinoma"
] | 12,133 | 1 |
ENSG00000168476 | REEP4 | Receptor accessory protein 4 | [
"Q9H6H4"
] | 8 | 22138020-22141951 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA042683"
] | [
"C8orf20",
"FLJ22246",
"FLJ22277",
"PP432",
"Yip2c"
] | [
"Predicted membrane proteins"
] | [
"Cell cycle",
"Cell division",
"Mitosis"
] | [] | [] | [
"Endoplasmic reticulum"
] | [] | [] | [] | Supported | Approved | null | 145 | No | Yes | Cluster 10: Non-specific - Membrane trafficking | Cluster 20: Macrophages & Microglia - Immune response | Cluster 40: Non-specific - Unknown function | Cluster 85: Squamous epithelial cells - Keratinization | Cluster 81: Squamous epithelium - Keratinization | Tissue enhanced | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enhanced | Detected in many | null | Low immune cell specificity | Detected in all | null | 2 | 0 | 2 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma"
] | 12,134 | 5 |
ENSG00000168477 | TNXB | Tenascin XB | [
"P22105"
] | 6 | 32041153-32115334 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA016017",
"HPA070464"
] | [
"HXBL",
"TN-X",
"TNX",
"TNXB1",
"TNXB2",
"TNXBS",
"XB",
"XBS"
] | [
"Disease related genes",
"Human disease related genes",
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Cell adhesion"
] | [] | [
"Disease variant",
"Ehlers-Danlos syndrome"
] | [
"Vesicles"
] | [] | [
"Secreted to extracellular matrix"
] | [
"Cell adhesion"
] | Supported | null | null | 1 | null | null | null | Cluster 15: Non-specific - Transcription | Cluster 64: Connective tissue cells - ECM organization | Cluster 105: Non-specific - Mixed function | Cluster 4: Adrenal gland - Steroid metabolism | Tissue enhanced | Detected in many | null | Low cancer specificity | Detected in some | null | Low cancer specificity | Detected in many | null | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 1 | 0 | 1 | [
"Liver Hepatocellular Carcinoma"
] | [] | [
"Liver Hepatocellular Carcinoma"
] | 12,135 | 5 |
ENSG00000168481 | LGI3 | Leucine rich repeat LGI family member 3 | [
"Q8N145"
] | 8 | 22146830-22157084 | Evidence at protein level | Evidence at transcript level | Evidence at transcript level | Evidence at protein level | [] | [] | [
"Plasma proteins",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Exocytosis"
] | [] | [
"Disease variant",
"Intellectual disability"
] | [] | [] | [
"Secreted in brain"
] | [
"Other"
] | null | null | null | null | null | null | null | Cluster 28: Oligodendrocytes - Mixed function | Cluster 69: Skin cancer - ECM organization | Cluster 80: Oligodendrocytes - Myelination | Cluster 3: Oligodendrocytes - Myelination | Tissue enriched | Detected in many | 6 | Cancer enriched | Detected in single | 28 | Group enriched | Detected in many | 5 | Cell type enhanced | Detected in some | null | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,136 | 9 |
ENSG00000168484 | SFTPC | Surfactant protein C | [
"P11686"
] | 8 | 22156913-22164479 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA010928"
] | [
"BRICD6",
"PSP-C",
"SFTP2",
"SMDP2",
"SP-C"
] | [
"Disease related genes",
"Human disease related genes",
"Predicted intracellular proteins",
"Predicted secreted proteins"
] | [
"Gaseous exchange"
] | [] | [
"Disease variant"
] | [] | [] | [
"Secreted in other tissues"
] | [
"Other"
] | null | Enhanced | null | 138 | null | null | null | Cluster 11: White matter - Signal transduction | Cluster 34: Testis cancer - Unknown function | Cluster 81: Alveolar cells - Lung function | Cluster 13: Lung - Secretion | Tissue enriched | Detected in many | 794 | Group enriched | Detected in some | 6 | Group enriched | Detected in many | 279 | Cell type enriched | Detected in some | 6 | Not detected in immune cells | Not detected | null | 0 | 0 | 0 | [] | [] | [] | 12,137 | 9 |
ENSG00000168487 | BMP1 | Bone morphogenetic protein 1 | [
"P13497"
] | 8 | 22165140-22212326 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA014572"
] | [
"BMP-1",
"PCOLC"
] | [
"Disease related genes",
"Enzymes",
"Human disease related genes",
"Metabolic proteins",
"Plasma proteins",
"Potential drug targets",
"Predicted secreted proteins"
] | [
"Chondrogenesis",
"Differentiation",
"Osteogenesis"
] | [
"Cytokine",
"Developmental protein",
"Growth factor",
"Hydrolase",
"Metalloprotease",
"Protease"
] | [
"Disease variant",
"Osteogenesis imperfecta"
] | [] | [] | [
"Secreted to extracellular matrix"
] | [
"Cytokine"
] | null | Enhanced | null | 4 | null | null | Cluster 33: Non-specific - ATP binding | Cluster 54: Immune cells - T cell receptor | Cluster 15: Kidney cancer - Membrane components | Cluster 81: Alveolar cells - Lung function | Cluster 14: Adipose tissue - Angiogenesis | Low tissue specificity | Detected in many | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Cell type enriched | Detected in many | 4 | Not detected in immune cells | Not detected | null | 1 | 2 | 0 | [] | [
"Lung Adenocarcinoma"
] | [
"Lung Adenocarcinoma"
] | 12,138 | 7 |
ENSG00000168488 | ATXN2L | Ataxin 2 like | [
"Q8WWM7"
] | 16 | 28822999-28837237 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA041506",
"HPA043391",
"HPA071955"
] | [
"A2D",
"A2lp"
] | [
"Plasma proteins",
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Cytosol"
] | [] | [] | [] | Enhanced | Approved | null | 37 | null | null | Cluster 30: Non-specific - DNA binding | Cluster 4: Non-specific - mRNA splicing & Cell cycle | Cluster 13: Non-specific - Mixed function | Cluster 20: Non-specific - Transcription regulation | Cluster 67: Testis - Mixed function | Low tissue specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cancer specificity | Detected in all | null | Low cell type specificity | Detected in all | null | Low immune cell specificity | Detected in many | null | 3 | 2 | 2 | [] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | [
"Kidney Renal Clear Cell Carcinoma",
"Liver Hepatocellular Carcinoma",
"Pancreatic Adenocarcinoma"
] | 12,139 | 2 |
ENSG00000168490 | PHYHIP | Phytanoyl-CoA 2-hydroxylase interacting protein | [
"Q92561"
] | 8 | 22219703-22232101 | Evidence at protein level | Evidence at protein level | Evidence at protein level | Evidence at protein level | [
"HPA068030",
"HPA069318"
] | [
"DYRK1AP3",
"KIAA0273",
"PAHX-AP"
] | [
"Predicted intracellular proteins"
] | [] | [] | [] | [
"Mitochondria"
] | [
"Nucleoplasm"
] | [] | [] | Supported | Approved | null | 10 | null | null | null | Cluster 51: Neurons - Mixed function | Cluster 72: Neuronal - Signal transduction | Cluster 2: Cerebellar granular cells - Neuronal signaling | Cluster 10: Brain - Synaptic signal transduction | Tissue enriched | Detected in many | 6 | Low cancer specificity | Detected in some | null | Cancer enhanced | Detected in many | null | Cell type enhanced | Detected in many | null | Not detected in immune cells | Not detected | null | 3 | 0 | 3 | [
"Breast Invasive Carcinoma",
"Rectum Adenocarcinoma"
] | [
"Stomach Adenocarcinoma"
] | [
"Breast Invasive Carcinoma",
"Rectum Adenocarcinoma",
"Stomach Adenocarcinoma"
] | 12,140 | 7 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.